Mark Ragosa Kiniksa Pharmaceuticals, Ltd. (KNSA) insider trading activity

Mark Ragosa is CHIEF FINANCIAL OFFICER of Kiniksa Pharmaceuticals, Ltd.. Currently has a direct ownership of 27,009 shares of KNSA, which is worth approximately $753,010. The most recent transaction as insider was on Jun 03, 2025, when has been sold 18,299 shares (Class A Ordinary Share) at a price of $28.8 per share, resulting in proceeds of $527,011. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 27K

1.93% 3M change

40.28% 12M change

Total Value Held $753,010

Mark Ragosa Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 03 2025	SELL Open market or private sale	$527,011 $28.8 p/Share	18,299 Reduced 40.39%	27,009 Class A Ordinary Share
Jun 03 2025	BUY Exercise of conversion of derivative security	$329,382 $18.0 p/Share	18,299 Added 28.77%	45,308 Class A Ordinary Share
May 01 2025	SELL Open market or private sale	$698,919 $27.8 p/Share	25,141 Reduced 48.21%	27,009 Class A Ordinary Share
May 01 2025	BUY Exercise of conversion of derivative security	$448,515 $17.84 p/Share	25,141 Added 32.53%	52,150 Class A Ordinary Share
Apr 30 2025	SELL Open market or private sale	$572,795 $26.95 p/Share	21,254 Reduced 44.04%	27,009 Class A Ordinary Share
Apr 30 2025	BUY Exercise of conversion of derivative security	$359,192 $16.9 p/Share	21,254 Added 30.57%	48,263 Class A Ordinary Share
Apr 29 2025	SELL Open market or private sale	$1,075,620 $25.61 p/Share	42,000 Reduced 60.86%	27,009 Class A Ordinary Share
Apr 29 2025	BUY Exercise of conversion of derivative security	$651,420 $15.51 p/Share	42,000 Added 37.83%	69,009 Class A Ordinary Share
Apr 26 2025	SELL Payment of exercise price or tax liability	$10,231 $21.36 p/Share	479 Reduced 1.74%	27,009 Class A Ordinary Share
Apr 26 2025	BUY Exercise of conversion of derivative security	-	990 Added 3.48%	27,488 Class A Ordinary Share
Apr 07 2025	SELL Payment of exercise price or tax liability	$26,424 $20.28 p/Share	1,303 Reduced 4.69%	26,498 Class A Ordinary Share
Apr 07 2025	BUY Exercise of conversion of derivative security	-	2,694 Added 8.83%	27,801 Class A Ordinary Share
Apr 01 2025	SELL Payment of exercise price or tax liability	$35,202 $21.77 p/Share	1,617 Reduced 6.05%	25,107 Class A Ordinary Share
Apr 01 2025	BUY Exercise of conversion of derivative security	-	3,342 Added 11.12%	26,724 Class A Ordinary Share
Mar 20 2025	SELL Open market or private sale	$368,465 $23.11 p/Share	15,944 Reduced 40.54%	23,382 Class A Ordinary Share
Mar 20 2025	BUY Exercise of conversion of derivative security	$206,793 $12.97 p/Share	15,944 Added 28.85%	39,326 Class A Ordinary Share
Mar 19 2025	SELL Open market or private sale	$205,104 $23.1 p/Share	8,879 Reduced 27.52%	23,382 Class A Ordinary Share
Mar 19 2025	BUY Exercise of conversion of derivative security	$115,160 $12.97 p/Share	8,879 Added 21.58%	32,261 Class A Ordinary Share
Mar 17 2025	SELL Open market or private sale	$264,818 $23.1 p/Share	11,464 Reduced 32.9%	23,382 Class A Ordinary Share
Mar 17 2025	BUY Exercise of conversion of derivative security	$148,688 $12.97 p/Share	11,464 Added 24.75%	34,846 Class A Ordinary Share
Mar 16 2025	SELL Payment of exercise price or tax liability	$10,129 $22.61 p/Share	448 Reduced 1.88%	23,382 Class A Ordinary Share
Mar 16 2025	BUY Exercise of conversion of derivative security	-	872 Added 3.53%	23,830 Class A Ordinary Share
Mar 12 2025	SELL Open market or private sale	$809,277 $22.25 p/Share	36,372 Reduced 61.3%	22,958 Class A Ordinary Share
Mar 12 2025	BUY Exercise of conversion of derivative security	$435,372 $11.97 p/Share	36,372 Added 38.01%	59,330 Class A Ordinary Share
Dec 09 2024	SELL Open market or private sale	$403,226 $21.38 p/Share	18,860 Reduced 45.1%	22,958 Class A Ordinary Share

Mark Ragosa

CHIEF FINANCIAL OFFICER

Hamilton, D0

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KNSA shares.

Notify only if

Value

Insider Trading

Get notified when an Kiniksa Pharmaceuticals, Ltd. insider buys or sells KNSA shares.

Notify only if

Operation

Value

Type

News

Receive news related to Kiniksa Pharmaceuticals, Ltd.

Track Activities on KNSA

Account